Clinicians have a new line of weapons in their arsenal to treat recurring nasal polyps. Over the past year several new monoclonal antibody-based biologic drugs have been approved to treat the ...

Females have a higher odds of chronic rhinosinusitis (CRS) without nasal polyps than men, according to a study published online Oct. 23 in JAMA Otolaryngology-Head & Neck Surgery. Richard G. Chiu, ...

The U.S. Food and Drug Administration approved Tezspire (tezepelumab-ekko; Amgen) for the add-on maintenance treatment of inadequately controlled chronic rhinosinusitis with nasal polyps (CRSwNP) in ...

AstraZeneca and Amgen's Tezspire (tezepelumab) has been approved in the European Union (EU) as an add-on therapy with intranasal corticosteroids for the treatment of adult patients with severe chronic ...

Approval based on WAYPOINT Phase III results demonstrating reduced nasal polyp severity and nasal congestion, near-elimination of the need for surgery and significantly reduced systematic ...

Investing.com -- AstraZeneca and Amgen have received European Union approval for Tezspire as an add-on therapy for adults with severe chronic rhinosinusitis with nasal polyps (CRSwNP) who haven’t ...

Dublin, Oct. 22, 2025 (GLOBE NEWSWIRE) -- The "Nasal Polyps - Pipeline Insight, 2025" has been added to ResearchAndMarkets.com's offering. The Nasal Polyps - Pipeline Insight, 2025 report offers ...

Tezspire is the first biologic approved for CRSwNP targeting TSLP, expanding its respiratory indications. The drug acts on airway epithelium, inhibiting TSLP, an early-stage inflammatory cytokine. The ...

A randomized placebo-controlled Finnish study showed that aspirin therapy does not provide significant relief for people suffering from chronic rhinosinusitis with nasal polyps who are hypersensitive ...

Nasal rinses use saline water to clean nasal passages and may help with symptoms of polyps. Eucalyptus oil has antimicrobial properties that may help stop bacterial growth and improve congestion.